Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease

New England Journal of Medicine

Volumn 341, Issue 2, 1999, Pages 70-76

  Pitt, Bertram ^a,g   Waters, David ^b   Brown, William Virgil ^h   Van Boven, Ad J ^c   Schwartz, Leonard ^h   Title, Lawrence M ^d   Eisenberg, Daniel ^e   Shurzinske, Linda ^f   McCormick, Lisa S ^f  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b HARTFORD HOSPITAL   (United States)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^e Saint Joseph Medical Center   (United States)

^f PFIZER INC   (United States)

^g UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; CHOLESTEROL; LOW DENSITY LIPOPROTEIN;

ADULT; ANGINA PECTORIS; ANGIOPLASTY; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FEMALE; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL, LDL; CORONARY DISEASE; FEMALE; HEPTANOIC ACIDS; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PYRROLES; QUALITY OF LIFE; RISK; TREATMENT OUTCOME;

EID: 0033536298     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199907083410202     Document Type: Article

References (14)

1. Parisi AF, Folland ED, Hartigan P. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med 1992;326:10-6.
2. Hueb WA, Bellotti G, de Oliveira SA, et al. The Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses. J Am Coll Cardiol 1995;26:1600-5.
3. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. Lancet 1997;350:461-8.
4. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
5. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001-9.
6. McCormick LS, Black DM, Waters D, Brown WV, Pitt B. Rationale, design, and baseline characteristics of a trial comparing aggressive lipid lowering with Atorvastatin Versus Revascularization Treatments (AVERT). Am J Cardiol 1997;80:1130-3.
7. Campeau L. Grading of angina pectoris. Circulation 1976;54:522-3.
8. Janicki JS, Weber KT. Equipment and protocols to evaluate the exercise response. In: Janicki JS, Weber KT, eds. Cardiopulmonary exercise testing. Section 9. Philadelphia: W.B. Saunders, 1986:147.
9. Brasseur LA, Mairaux PH, Kandouci AB, Detry JM. Respiratory and metabolic parameters during submaximal and maximal exercise in normal men. In: Rulli V, Messin R, Denolin H, eds. Normal values in adult ergometry according to age, sex, and training. Torino, Italy: Schiapparelli Farmaceutici, 1983:3-14 (pamphlet).
10. Geller NL, Pocock SJ. Design and analysis of clinical trials with group sequential stopping rules. In: Peace KE, ed. Biopharmaceutical statistics for drug development. New York: Marcel Dekker, 1988:489-508.
11. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). 1. Conceptual framework and item selection. Med Care 1992; 30:473-83.
12. Ware JE Jr, Snow KK, Kosinski M, Gandek B. SF-36 health survey: manual and interpretation guide. Boston: Health Institute, New England Medical Center, 1993.
13. Forrester JS, Shah PK. Lipid lowering versus revascularization: an idea whose time (for testing) has come. Circulation 1997;96:1360-2.
14. Waters D. Plaque stabilization: a mechanism for the beneficial effect of lipid-lowering therapies in angiographic studies. Prog Cardiovasc Dis 1994;37:107-20.